SFCM
TARS icon

Seven Fleet Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Seven Fleet Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
19,800
+15,300
+340% +$1.07M 0.44% 51
2025
Q4 		$368K Buy
+4,500
New +$336K 0.25% 54

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Seven Fleet Capital Management's TARS Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Tarsus Pharmaceuticals (TARS) stake by 340% in Q1 2026, buying an estimated $1.07M and bringing the position to 19,800 shares worth $1.39M. The position accounts for 0.44% of the portfolio, ranked #51.

Seven Fleet Capital Management first reported a position in TARS in Q4 2025 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Seven Fleet Capital Management held 19,800 shares of Tarsus Pharmaceuticals worth $1.39M as of Q1 2026.
  • Seven Fleet Capital Management bought 15,300 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $1.07M.
  • Tarsus Pharmaceuticals made up 0.44% of Seven Fleet Capital Management's portfolio in Q1 2026, its #51 holding.
  • Seven Fleet Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.